Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs
- PMID: 27430019
- PMCID: PMC4942133
- DOI: 10.15226/2374-6890/2/4/00131
Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs
Abstract
Background: Diabetic Retinopathy (DR) is a leading cause of blindness worldwide even though successful treatments exist. Improving screening and treatment could avoid many cases of vision loss. However, due to an increasing prevalence of diabetes, traditional in-person screening for DR for every diabetic patient is not feasible. Telemedicine is one viable solution to provide high-quality and efficient screening to large number of diabetic patients.
Purpose: To provide a narrative review of large DR telemedicine screening programs.
Methods: Articles were identified through a comprehensive search of the English-language literature published between 2000 and 2014. Telemedicine screening programs were included for review if they had published data on at least 150 patients and had available validation studies supporting their model. Screening programs were then categorized according to their American Telemedicine Association Validation Level.
Results: Seven programs from the US and abroad were identified and included in the review. Three programs were Category 1 programs (Ophdiat, EyePacs, and Digiscope), two were Category 2 programs (Eye Check, NHS Diabetic Eye Screening Program), and two were Category 3 programs (Joslin Vision Network, Alberta Screening Program). No program was identified that claimed category 4 status. Programs ranged from community or city level programs to large nationwide programs including millions of individuals. The programs demonstrated a high level of clinical accuracy in screening for DR. There was no consensus amongst the programs regarding the need for dilation, need for stereoscopic images, or the level of training for approved image graders.
Conclusion: Telemedicine programs have been clinically validated and successfully implemented across the globe. They can provide a high-level of clinical accuracy for screening for DR while improving patient access in a cost-effective and scalable manner.
Keywords: Diabetic retinopathy; Screening programs; Telemedicine.
Similar articles
-
Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review.Cost Eff Resour Alloc. 2020 Apr 6;18:16. doi: 10.1186/s12962-020-00211-1. eCollection 2020. Cost Eff Resour Alloc. 2020. PMID: 32280309 Free PMC article. Review.
-
Telemedicine in diabetic retinopathy screening in India.Indian J Ophthalmol. 2021 Nov;69(11):2977-2986. doi: 10.4103/ijo.IJO_1442_21. Indian J Ophthalmol. 2021. PMID: 34708732 Free PMC article. Review.
-
Operational Components of Telemedicine Programs for Diabetic Retinopathy.Curr Diab Rep. 2016 Dec;16(12):128. doi: 10.1007/s11892-016-0814-7. Curr Diab Rep. 2016. PMID: 27796778 Review.
-
Diabetic retinopathy screening and the use of telemedicine.Curr Opin Ophthalmol. 2015 May;26(3):167-72. doi: 10.1097/ICU.0000000000000142. Curr Opin Ophthalmol. 2015. PMID: 25759962 Review.
-
Clinical Components of Telemedicine Programs for Diabetic Retinopathy.Curr Diab Rep. 2016 Dec;16(12):129. doi: 10.1007/s11892-016-0813-8. Curr Diab Rep. 2016. PMID: 27796779 Review.
Cited by
-
Tele-health in pediatric ophthalmology: Promises and pitfalls.Indian J Ophthalmol. 2021 Mar;69(3):740-742. doi: 10.4103/ijo.IJO_229_21. Indian J Ophthalmol. 2021. PMID: 33595515 Free PMC article. No abstract available.
-
Evaluation of Sensitivity and Specificity of Acuity 360 Telemedicine Vision Screening System.Clin Ophthalmol. 2024 Dec 19;18:3853-3859. doi: 10.2147/OPTH.S476868. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39720187 Free PMC article.
-
Evaluation of Artificial Intelligence-Based Grading of Diabetic Retinopathy in Primary Care.JAMA Netw Open. 2018 Sep 7;1(5):e182665. doi: 10.1001/jamanetworkopen.2018.2665. JAMA Netw Open. 2018. PMID: 30646178 Free PMC article.
-
Could telehealth help eye care practitioners adapt contact lens services during the COVID-19 pandemic?Cont Lens Anterior Eye. 2020 Jun;43(3):204-207. doi: 10.1016/j.clae.2020.04.002. Epub 2020 Apr 18. Cont Lens Anterior Eye. 2020. PMID: 32336578 Free PMC article.
-
Proposed measures to be taken by ophthalmologists during the coronavirus disease 2019 pandemic: Experience from Chang Gung Memorial Hospital, Linkou, Taiwan.Taiwan J Ophthalmol. 2020 May 6;10(2):80-86. doi: 10.4103/tjo.tjo_21_20. eCollection 2020 Apr-Jun. Taiwan J Ophthalmol. 2020. PMID: 32874834 Free PMC article.
References
-
- Kobrin Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic epidemiology. 2007;14(4):179–183. - PubMed
-
- Group ETDRSR. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796–1806. - PubMed
-
- Paz SH, Varma R, Klein R, Wu J, Azen SP Group LALES. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. Ophthalmology. 2006;113(8):1372–1377. - PubMed
-
- Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003;110(10):1952–1959. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources